{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:04:30Z","timestamp":1784739870195,"version":"3.55.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","surgpath.theclinics.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.path.2015.09.007","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T01:34:14Z","timestamp":1456882454000},"page":"11-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["B-cell Non-Hodgkin Lymphomas with Plasmacytic Differentiation"],"prefix":"10.1016","volume":"9","author":[{"given":"Charles M.","family":"Harmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2015.09.007_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"194","article-title":"Lymphoplasmacytic lymphoma","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2015.09.007_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2015.09.007_bib4","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib5","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","article-title":"MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia","volume":"27","author":"Jimenez","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2015.09.007_bib6","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib7","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1182\/blood-2012-06-436329","article-title":"MYD88 L265P mutation in Waldenstrom macroglobulinemia","volume":"121","author":"Poulain","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.5858\/arpa.2014-0322-OA","article-title":"Significance of MYD88 L265P mutation status in the subclassification of low-grade B-Cell lymphoma\/leukemia","volume":"139","author":"Insuasti-Beltran","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2015.09.007_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000360992","article-title":"Outcome disparities among ethnic subgroups of Waldenstrom's macroglobulinemia: a population-based study","volume":"86","author":"Ailawadhi","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.path.2015.09.007_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajh.23922","article-title":"Waldenstrom macroglobulinemia: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Gertz","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.path.2015.09.007_bib11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/01.pas.0000182405.65041.8b","article-title":"Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens","volume":"29","author":"Arber","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1309\/AJCP8FOIVTB6LBER","article-title":"Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation","volume":"136","author":"Lin","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2009.34","article-title":"Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom's macroglobulinemia","volume":"22","author":"Morice","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1309\/3G1XDX0DVHBNVKB4","article-title":"Immunophenotypic profile of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia","volume":"124","author":"Konoplev","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/AJCP0YGM8BLFYHJY","article-title":"Nuclear protein dysregulation in lymphoplasmacytic lymphoma\/waldenstrom macroglobulinemia","volume":"139","author":"Roberts","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1309\/AJCP6ZODWV1CIDME","article-title":"Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature","volume":"143","author":"Bassarova","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.path.2015.09.007_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1309\/AJCP0N7IELYUNJGZ","article-title":"IgM multiple myeloma: pathologic evaluation of a rare entity","volume":"140","author":"King","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ajh.21845","article-title":"IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia","volume":"85","author":"Schuster","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.path.2015.09.007_bib20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","article-title":"MYD88 (L265P) Somatic Mutation in Marginal Zone B-cell Lymphoma","volume":"39","author":"Martinez-Lopez","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2014.120","article-title":"MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma","volume":"28","author":"Hamadeh","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/bjh.13264","article-title":"Overall survival and competing risks of death in patients with Waldenstrom macroglobulinaemia: an analysis of the surveillance, epidemiology and end results database","volume":"169","author":"Castillo","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2015.09.007_bib23","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstrom macroglobulinemia","volume":"113","author":"Morel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib24","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2014-01-550905","article-title":"Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia","volume":"123","author":"Treon","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3324\/haematol.2012.070458","article-title":"Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom's macroglobulinemia","volume":"98","author":"Nguyen-Khac","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.path.2015.09.007_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2006.06389.x","article-title":"6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis","volume":"136","author":"Ocio","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2015.09.007_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3816\/CLM.2009.n.008","article-title":"Prognostic relevance of 6q deletion in Waldenstrom's macroglobulinemia: a multicenter study","volume":"9","author":"Chang","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.path.2015.09.007_bib28","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"214","article-title":"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib29","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"185","article-title":"Splenic marginal zone lymphoma","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib30","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"218","article-title":"Nodal marginal zone lymphoma","author":"Campo","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11894-012-0296-y","article-title":"Helicobacter pylori in gastric malignancies","volume":"14","author":"Bhandari","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.path.2015.09.007_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","article-title":"Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type","volume":"24","author":"Thieblemont","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.path.2015.09.007_bib33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.path.2015.09.007_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Lecuit","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2015.09.007_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjh.12703","article-title":"Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe","volume":"164","author":"Adam","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2015.09.007_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.semcancer.2013.09.004","article-title":"Marginal zone lymphomas and infectious agents","volume":"23","author":"Ferreri","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.path.2015.09.007_bib37","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2015.09.007_bib38","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/annonc\/mdm375","article-title":"Pathology and clinical course of MALT lymphoma with plasmacytic differentiation","volume":"18","author":"Wohrer","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.path.2015.09.007_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1309\/AJCP63OGXHXCSKSC","article-title":"Marginal zone lymphomas with plasmacytic differentiation and related disorders","volume":"136","author":"Molina","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2559.1992.tb00425.x","article-title":"The lymphoepithelial lesion of gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): an ultrastructural study","volume":"21","author":"Papadaki","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2015.09.007_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1703","article-title":"Gastrointestinal lymphoma: where morphology meets molecular biology","volume":"205","author":"Isaacson","year":"2005","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib42","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2015.09.007_bib43","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/leu.2009.108","article-title":"Identification of MNDA as a new marker for nodal marginal zone lymphoma","volume":"23","author":"Kanellis","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2015.09.007_bib44","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.humpath.2014.04.004","article-title":"Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma","volume":"45","author":"Metcalf","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib45","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.pas.0000213275.60962.2a","article-title":"The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America","volume":"30","author":"Remstein","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib46","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1158\/1078-0432.CCR-14-0496","article-title":"Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas","volume":"20","author":"Zucca","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2015.09.007_bib47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.leu.2404517","article-title":"The pathogenesis of MALT lymphomas: where do we stand?","volume":"21","author":"Sagaert","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2015.09.007_bib48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0046-8177(96)90071-4","article-title":"Detection of immunoglobulin heavy chain gene rearrangement by polymerase chain reaction in chronic active gastritis associated with Helicobacter pylori","volume":"27","author":"Hsi","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib49","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.humpath.2011.11.004","article-title":"CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases","volume":"43","author":"Jaso","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib50","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A\u00a0clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib51","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","article-title":"Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project","volume":"17","author":"Nathwani","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2015.09.007_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","article-title":"Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy","volume":"357","author":"Liu","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.path.2015.09.007_bib53","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2013-02-486522","article-title":"Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature","volume":"122","author":"Kiesewetter","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib54","first-page":"92","article-title":"Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma","volume":"26","author":"Traverse-Glehen","year":"2012","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.path.2015.09.007_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.2006.06437.x","article-title":"Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease","volume":"136","author":"Arcaini","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2015.09.007_bib56","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00277-006-0160-y","article-title":"Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma","volume":"85","author":"Oh","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.path.2015.09.007_bib57","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","article-title":"Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review","volume":"98","author":"van den Brand","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.path.2015.09.007_bib58","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2559.2005.02309.x","article-title":"A\u00a0clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases","volume":"48","author":"Traverse-Glehen","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2015.09.007_bib59","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00000478-200306000-00006","article-title":"Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases","volume":"27","author":"Camacho","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPZQ1GXBBNG8OG","article-title":"Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases","volume":"132","author":"Salama","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib61","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)64087-4","article-title":"Unique phenotypic profile of monocytoid B cells: differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma","volume":"158","author":"Camacho","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib62","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3109\/10428194.2013.840888","article-title":"Nodal marginal zone lymphoma","volume":"55","author":"Angelopoulou","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.path.2015.09.007_bib63","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","article-title":"Splenic marginal zone lymphoma","volume":"101","author":"Franco","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hon.762","article-title":"Nodal and splenic marginal zone B cell lymphomas","volume":"23","author":"Mollejo","year":"2005","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.path.2015.09.007_bib65","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1309\/AJCP5GE1PSBMBZTW","article-title":"An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia","volume":"136","author":"Sherman","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib66","first-page":"601","article-title":"Absence of cyclin D1 protein expression in splenic marginal zone lymphoma","volume":"11","author":"Savilo","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib67","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma","volume":"154","author":"Mateo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib68","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q","volume":"86","author":"Sole","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.path.2015.09.007_bib69","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.path.2015.09.007_bib70","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.path.2015.09.007_bib71","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":"Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation","volume":"28","author":"Martinez","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2015.09.007_bib72","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2015.09.007_bib73","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"188","article-title":"Hairy cell leukemia","author":"Foucar","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib74","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"191","article-title":"Splenic B-cell lymphoma\/leukemia, unclassifiable","author":"Piris","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib75","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.5858\/arpa.2014-0291-CC","article-title":"Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings","volume":"138","author":"Behdad","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2015.09.007_bib76","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3109\/10428194.2012.743655","article-title":"Splenic marginal zone lymphoma: a population-based study on the 2001-2008 incidence and survival in the United States","volume":"54","author":"Liu","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.path.2015.09.007_bib77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/cncr.27773","article-title":"Survival of patients with marginal zone lymphoma: analysis of the surveillance, epidemiology, and end results database","volume":"119","author":"Olszewski","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.path.2015.09.007_bib78","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib79","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/bjh.12036","article-title":"Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma","volume":"159","author":"Else","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2015.09.007_bib80","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1586\/17474086.2013.845522","article-title":"Splenic marginal zone lymphoma: disease features and management","volume":"6","author":"Matutes","year":"2013","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.path.2015.09.007_bib81","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jcp.2010.076810","article-title":"Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas","volume":"63","author":"Chuang","year":"2010","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2015.09.007_bib83","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib84","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"256","article-title":"Plasmablastic lymphoma","author":"Stein","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib85","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.09.007_bib86","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/hupa.2002.124723","article-title":"AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment","volume":"33","author":"Carbone","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib87","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib88","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib89","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/cncr.27551","article-title":"Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy","volume":"118","author":"Castillo","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.path.2015.09.007_bib90","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib91","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1309\/AJCPENJ68FFBRIYB","article-title":"Plasma cell myeloma and related neoplasms","volume":"136","author":"Lorsbach","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib92","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"254","article-title":"ALK-positive large B-cell lymphoma","author":"Delsol","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib93","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/modpathol.2013.73","article-title":"ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements","volume":"26","author":"Valera","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib94","doi-asserted-by":"crossref","first-page":"529572","DOI":"10.1155\/2012\/529572","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma","volume":"2012","author":"Morgan","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.path.2015.09.007_bib95","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PAS.0000000000000319","article-title":"Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations","volume":"39","author":"Horn","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib96","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.09.007_bib97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2141.2000.02329.x","article-title":"Expression of MUM1\/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis","volume":"111","author":"Carbone","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2015.09.007_bib98","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"260","article-title":"Primary effusion lymphoma","author":"Said","year":"2008"},{"key":"10.1016\/j.path.2015.09.007_bib99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1634\/theoncologist.2009-0304","article-title":"Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma","volume":"15","author":"Castillo","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.path.2015.09.007_bib100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clml.2011.03.008","article-title":"HIV-negative plasmablastic lymphoma: not in the mouth","volume":"11","author":"Castillo","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.path.2015.09.007_bib101","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3109\/10428194.2010.516040","article-title":"Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma","volume":"51","author":"Castillo","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.path.2015.09.007_bib102","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10428194.2014.911867","article-title":"Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience","volume":"56","author":"Cattaneo","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.path.2015.09.007_bib103","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.leukres.2011.06.023","article-title":"Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review","volume":"35","author":"Liu","year":"2011","journal-title":"Leuk Res"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918115001130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918115001130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T23:55:37Z","timestamp":1654473337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918115001130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1875918115001130"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2015.09.007","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell Non-Hodgkin Lymphomas with Plasmacytic Differentiation","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}